Patent Docs

USPTO Program on Agricultural Innovation Advances

The U.S. Patent and Trademark Office will be hosting a virtual program entitled "Together in Innovation: Agricultural Advances" on February 28, 2023 from 3:00 pm to 4:00 pm (ET).  The program will cover the following topics:

• How diverse teams are an essential part of a successful business strategy
• The challenges that women innovators often face and overcome in agricultural innovation
• Valuable resources that innovators can use to protect their intellectual property (IP) and secure funding for their enterprises

Those interested in registering for the event, can do so here.

Webinar on Increasing Representation of Women in IP

Harrity & Harrity will be offering a webinar entitled "Diversity Dialogue ThinkTank: An Update on Programs to Increase the Representation of Women in IP" on March 1, 2023 at 3:00 pm (ET).  Elaine Spector of Harrity & Harrity, LLP; Meredith Struby of Meunier Carlin & Curfman LLC; Lisa Mueller of Casimir Jones, S.C.; and Carlyn Burton of Osha Bergman Watanabe & Burton LLP will provide an update on the progress each firm has made in the implementation of their new programs for increasing the representation of women in patent law and the anticipated impact on the field of patent law.

Those interested in attending the webinar can register here.

ACI 18th Annual Paragraph IV Disputes Conference

The American Conference Institute (ACI) will be presenting its 18th Annual Paragraph IV Disputes Conference on April 19-20, 2023 in New York City.  As in the past, this curated program will not only address "hot" topics but also will put the issues within the context of pre-suit considerations, case filings, final adjudication, and every step in between.

This year's co-chairs include Honorable Kathleen M. O'Malley (Of Counsel, Irell & Manella LLP), Neema Kumar (Vice President IP, North America, Sandoz), and Serena Farquharson Torres (Executive Director, Assistant General Counsel, Bristol Myers Squibb).

The Paragraph IV Disputes Conference has gathered over 30 sponsors, including Akin Gump, King & Spalding, Axinn, Steptoe & Johnson, Knobbe Martens, and Loeb & Loeb.

Joining participants will be Hatch-Waxman litigators, in-house advisers, Chief IP and senior IP/Patent counsel from leading brand name and generic pharmaceutical companies, who will discuss, debate, and analyze the latest trends, decisions, legislative and regulatory advancements affecting Hatch-Waxman litigation.  The Conference will also feature Judges — both from the federal judiciary, and USPTO's PTAB, and officials from the FTC and the FDA.

The brochure, agenda, and registration information can be found here.  ACI can be contacted by e-mail at  customerservice@americanconference.com and by telephone at 1-888-224-2480.

Patent Docs readers can save 10% by using promo code: D10-999-PATENTDOCS.

Conference & CLE Calendar

February 21, 2023 - European biotech patent law update (D Young & Co) - 9:00 am, noon, and 5:00 pm (GMT)

February 21, 2023- "Unlocking the Power of Conversational AI in IP Law: A Look at ChatGPT & its Applications" (Black Hills IP) - 12:00 pm (CT)

February 21, 2023 - "Section 112 Issues in ANDA and Biologics Litigation" (Federal Circuit Bar Association Patent Litigation Committee and ANDA & BPCIA Proceedings Subcommittee) - 1:00 pm to 2:30 pm (ET)

February 22, 2023 - Women's Entrepreneurship (WE) event (U.S. Patent and Trademark Office) - 11:30 am and 12:45 pm (MT), Phoenix, AZ

February 23, 2023 - "The Unified Patent Court (UPC) is around the corner! -- What you need to know about UPC opt-outs and the latest news" (Questel) - 4:00 pm (GMT)

February 23, 2023 - "Navigating the Patent Gauntlet: Considerations for New Product Launch" (Fitch Even) - 12:00 pm to 1:00 pm (ET)

February 23, 2023 - "Evaluating and Acquiring Patent Portfolios: Key Considerations -- Structuring the Transaction, Conducting Due Diligence, Drafting and Negotiating Key Provisions" (Strafford) - 1:00 to 2:30 pm (EST)

February 23, 2023 - Panel discussion on the duty of disclosure and duty of reasonable inquiry (U.S. Patent and Trademark Office) - 3:00 pm to 4:00 pm ET.

March 21-22, 2023 - National Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies (American Conference Institute) - Boston, MA

European Biotech Patent Law Webinar

D Young & Co will be offering its next European biotech patent law update on February 21, 2023.  The webinar will be offered at three times:  9:00 am, noon, and 5:00 pm (GMT).  D Young & Co European Patent Attorneys Simon O'Brien and Tom Pagdin will discuss the latest European biotech patent case law developments.

While there is no fee to participate, attendees must register in advance.  Those wishing to register can do so here.

Webinar on Conversational AI in IP Law

Black Hills IP will be offering a webinar entitled "Unlocking the Power of Conversational AI in IP Law: A Look at ChatGPT & its Applications" on February 21, 2023 at 12:00 pm (CT).  Manjeet Rege, Director of the Center for Applied Artificial Intelligence at the University of St. Thomas, and Thomas Marlow, Chief Technology Officer, Black Hills IP will convey the components of AI, generative AI, and conversation AI, leading to a discussion and demonstration of ChatGPT.  Following the demo, Mr. Marlow will delve into the effects of generative AI in the IP legal world and how we can use ChatGPT for the purposes of optimization.

While there is no cost to participate in the program, those interested in attending the webinar can register here.

FCBA Program on Section 112 Issues in ANDA and Biologics Litigation

The Federal Circuit Bar Association (FCBA) Patent Litigation Committee and ANDA & BPCIA Proceedings Subcommittee will be offering a remote program entitled "Section 112 Issues in ANDA and Biologics Litigation" on February 21, 2023 from 1:00 pm to 2:30 pm (ET).  Jenna Deneault of Groombridge Wu will moderate a panel consisting of Jill Schmidt of Genentech, Inc.; Laura Lydigsen of Crowell & Moring LLP; Hassen Sayeed of O'Melveny & Myers LLP; and Josephine Young of Groombridge Wu.  The panel will review the current state of section 112 issues in ANDA and biologics litigation and discuss where we will go from here.

The webinar is complimentary for FCBA members, $50 for government/academic/retired/student non-members, and $175 for private practitioner non-members.  Those interested in registering for the program, can do so here.

USPTO Women's Entrepreneurship Event

The U.S. Patent and Trademark Office will be offering its next Women's Entrepreneurship (WE) event from 11:30 am and 12:45 pm (MT) on February 22, 2023 at the Phoenix Bioscience Core (850 PBC) in Phoenix, AZ.  The event will kick-off with a fireside chat between Kathi Vidal, Under Secretary of Commerce for Intellectual Property and Director of the USPTO, and Sally Morton, Executive Vice President & Professor, ASU Knowledge Enterprise, and will be followed by a panel of experts sharing stories and tips on how to secure options for funding a small business.

Those interested in registering for the event can do so here.

Webinar on Unified Patent Court

Questel and will be offering a webinar entitled "The Unified Patent Court (UPC) is around the corner! -- What you need to know about UPC opt-outs and the latest news" on February 23, 2023 at 4:00 pm (GMT).  Marie-Noëlle De La Fouchardière of Novagraaf Technologies, Michael Braun of Berggren, and Viviane Chilton of Questel will provide insights into the very latest developments and how to successfully prepare, implement, and monitor opt-outs, and discuss the following topics:

• The latest news on the implementation of the UPC
• Updates on UPC opt-out requirements
• How to prepare efficiently for opt-outs
• What you should consider when deciding how to lodge opt-outs
• Key advice on what to look out for after opting-out

There is no registration fee for this webinar.  However, those interested in registering for the webinar, should do so here.

Webinar on Patent Considerations for New Product Launch

Fitch Even will be offering a webinar entitled "Navigating the Patent Gauntlet: Considerations for New Product Launch" on February 23, 2023 from 12:00 pm to 1:00 pm (ET).  Nicholas T. Peters and David M. Kogan of Fitch Even will address the following topics:

• How to assess a new product and perform and analyze a patentability search
• How to perform a focused FTO search and identify potential risks
• Finding alternatives for proceeding when a potentially troublesome patent is identified during the FTO search
• What to do with a potentially troublesome pending patent application
• Comparison of the inter partes review, reexamination, and litigation options to reduce patent infringement risk

While there is no cost to participate in the program, advance registration is required.  Those interested in attending the webinar can register here.

Webinar on Evaluating and Acquiring Patent Portfolios

Strafford will be offering a webinar entitled "Evaluating and Acquiring Patent Portfolios: Key Considerations -- Structuring the Transaction, Conducting Due Diligence, Drafting and Negotiating Key Provisions" on February 23, 2023 from 1:00 to 2:30 pm (EST).  Charles F. O'Brien of Cantor Colburn, Michael J. Lennon of Potomac Law Group, and Peter J. Toren of Anderson Kill will guide patent counsel on the key considerations for evaluating and acquiring patent portfolios, provide insight into strategic considerations and transaction structures as well as the key issues to consider when conducting patent portfolio due diligence, and offer best practices for drafting the provisions of a patent purchase agreement.  The webinar will review the following issues:

• What strategic considerations drive a patent portfolio acquisition?
• During due diligence, what should be included in the scope and status of the patent portfolio?

The registration fee for the webcast is $347.  Those interested in registering for the webinar, can do so here.

USPTO Virtual Panel Discussion on Duty of Disclosure and Duty of Reasonable Inquiry

The U.S. Patent and Trademark Office will be offering a virtual panel discussion on the duty of disclosure and duty of reasonable inquiry on February 23, 2023 from 3:00 pm to 4:00 pm ET.  Kimberly Braslow of AstraZeneca & Vice Chair of the AIPLA Food and Drug Committee will moderate a panel consisting of Robert A. Clarke, Mary Till, and Matthew Sked of the USPTO Office of Patent Legal Administration, and Ronald K. Jaicks of the USPTO Office of Enrollment and Discipline.  The panel will discuss and answer frequently asked questions that the USPTO has received from stakeholders regarding the duty of disclosure and duty of reasonable inquiry.

Those interested in registering for the webinar can do so here.

Conference & CLE Calendar

February 14, 2023 - "Orange Book Listing Recent Developments -- Impact on Prosecution of Pharmaceutical U.S. Patent Applications, Subsequent Orange Book Listings, Hatch Waxman Litigation" (Strafford) - 1:00 to 2:30 pm (EST)

February 14, 2023 - "The Myth of the Meritocracy Part 2 -- Countering Myths and Overcoming Bias" (Intellectual Property Owners Association) - 2:00 pm to 3:00 pm (ET)

February 15, 2023 - "Best Practices for Searching Non-Patent Literature" (Patent Information Users Group, Inc.) - 10:00 am to 11:00 am (EST)

February 15, 2023 - 2023 Patent Litigation Report (Lex Machina) - 9:00 am (PDT)

February 16, 2023 - "IPO Black History Month Event: Successes and Challenges Faced by Leaders in the Black IP Community" (Intellectual Property Owners Association Black IP Professionals Resource Group) - 2:00 pm to 3:00 pm (ET)

March 21-22, 2023 - National Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies (American Conference Institute) - Boston, MA

Webinar on Orange Book Listing Recent Developments

Strafford will be offering a webinar entitled "Orange Book Listing Recent Developments -- Impact on Prosecution of Pharmaceutical U.S. Patent Applications, Subsequent Orange Book Listings, Hatch Waxman Litigation" on February 14, 2023 from 1:00 to 2:30 pm (EST).  Adriana L. Burgy, Mark J. Feldstein, Thomas L. Irving, and Jill K. MacAlpine of Finnegan Henderson Farabow Garrett & Dunner, and Sarah Hooson of Merck Sharp & Dohme will guide patent counsel on recent Orange Book developments; discuss Orange Book listing practices and the implications for patent prosecution, listing, and litigation; and examine contemporary thought about Form 3542 and pitfalls to avoid.  The webinar will review the following issues:

• What are the changes and anticipated changes to the Orange Book?
• What strategies should counsel employ when listing pharmaceutical patents in the Orange Book?

The registration fee for the webcast is $347.  Those interested in registering for the webinar, can do so here.